<?xml version="1.0" encoding="UTF-8"?>
<p>The viremia profiles of CO HOSPs inoculated with WNV.IC and SLEV-prME/WNV.IC were indistinguishable (p&gt;0.05), but were higher (p&lt;0.05) than those of SLEV/IMP115, SLEV.IC and WNV-prME/SLEV.IC during 2–4 dpi (
 <xref ref-type="fig" rid="pntd.0006302.g001">Fig 1C</xref>). The viremia profiles for SLEV/IMP115, SLEV.IC and WNV-prME/SLEV.IC were statistically indistinguishable (p&gt;0.05) and peaked on 6 dpi (
 <xref ref-type="fig" rid="pntd.0006302.g001">Fig 1C</xref>), 2–3 dpi later than SLEV/IMP115 in California HOSPs (
 <xref ref-type="fig" rid="pntd.0006302.g001">Fig 1B</xref>). House sparrows inoculated with WNV.IC and SLEV-prME/WNV.IC produced indistinguishable (p&gt;0.05) peak mean titers of 5.9 ± 1.0 log
 <sub>10</sub> PFU/mL and 6.0 ± 1.8 log
 <sub>10</sub> PFU/mL, respectively (
 <xref ref-type="fig" rid="pntd.0006302.g002">Fig 2C</xref>). In contrast, SLEV/IMP115, SLEV.IC and WNV-prME/SLEV.IC produced lower (p&lt;0.05) peak mean titers of 4.4 ± 1.3 log
 <sub>10</sub> PFU/mL, 4.4 ± 1.0 log
 <sub>10</sub> PFU/mL and 3.0 ±1.5 log
 <sub>10</sub> PFU/mL, respectively (
 <xref ref-type="fig" rid="pntd.0006302.g002">Fig 2C</xref>). Mean peak titers for this latter group were not significantly different (p&lt;0.05). No mortality was observed in these CO HOSPs after primary infection (
 <xref ref-type="fig" rid="pntd.0006302.g003">Fig 3C</xref>).
</p>
